A look at which peptide treatments actually carry FDA approval as interest in them grows. The full story has the details.
Recap by typeshit. Full story at Buffalo News.
She talks with Annika Urban about combining GLP-1 treatment with behavioral coaching and telehealth care.
An opinion piece drawing on Sabrina Strings to tie GLP-1 culture, celebrity ads and Ozempic-friendly menus to class and belonging.
Oddo moved to DKK 305 and HSBC to DKK 280. Novo also shared a CagriSema subgroup analysis showing women lost 25% of body weight at 68 weeks.
MUSC Health suggests the familiar ABCs of heart health may change, with GLP-1 medications now part of cardiovascular prevention for some patients.
Pluang models what a $1,000 stake in Lilly could become by 2031, assuming 12.85% yearly returns after the drugmaker's revenue surge.
The bariatric surgeon says the options work differently, stopping matters, and he credits surgery with the strongest long-term data at BMI 40 and up.
Loading…